Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Jul 11:16:543.
doi: 10.1186/s12889-016-3236-1.

Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes

Carl D D'Ruiz  1 , Donald W Graff  2 , Edward Robinson  3
Affiliations
Randomized Controlled Trial

Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes

Carl D D'Ruiz et al. BMC Public Health. .

Abstract

Background: Electronic cigarettes (e-cigarettes) are popular alternatives to conventional cigarettes among adult smokers wishing to reduce their exposure to harmful smoke constituents. However, little information exists on the relative internal exposures resulting from the exclusive or dual use of e-cigarettes.

Methods: Measurements of product use; adverse events; changes in smoking urge; and blood, urine and exhaled breath biomarkers of exposure (BoE) representing toxicants believed to contribute to smoking related diseases were made at baseline and after five days of product use in 105 clinically-confined smokers randomized into groups that partially or completely substituted their usual brand combustible cigarette with commercial e-cigarettes, or discontinued all nicotine and tobacco products.

Results: Subjects switching to e-cigarettes had significantly lower levels (29 %-95 %) of urinary BoEs after 5 days. Nicotine equivalents declined by 25 %-40 %. Dual users who substituted half of their self-reported daily cigarette consumption with e-cigarettes experienced 7 %-38 % reductions, but had increases (1 %-20 %) in nicotine equivalents. Blood nicotine biomarker levels were lower in the cessation (75 %-96 %) and e-cigarette use groups (11 %-83 %); dual users had no significant reductions. All groups experienced significant decreases in exhaled CO (27 %-89 %). Exhaled NO increases (46 %-63 %) were observed in the cessation and e-cigarette use groups; dual users had minimal changes. By Day 5, all groups had greater reductions in smoking urge compared to cessation. However, reductions were larger in the dual use group. No serious adverse events were observed.

Conclusions: Exposures to harmful smoke toxicants were observed to be lower in smokers who completely or partially replaced their cigarettes with e-cigarettes over five days.

Trial registration: ClinicalTrials.gov NCT02385227.

Keywords: Adverse events; Biomarkers of exposure; Clinical trial; Electronic cigarettes; Exclusive and dual use; Nicotine cessation; Urge to smoke.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Urine biomarkers - Day 5 % change from Day −1
Fig. 2
Fig. 2
Blood biomarkers - Day 5 % change from Day −1
Fig. 3
Fig. 3
Exhaled Breath Biomarkers - Day 5 % Change from Day −1
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. U.S. Department of Health and Human Services . National center for chronic disease prevention and health promotion, office on smoking and health: the health consequences of smoking – 50 years of progress: a report of the surgeon general. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention (DHHS), National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
    1. Jamal A, Agaku IT, O’Connor E, King BA, Kenemer JB, Neff L. Current cigarette smoking among adults—United States, 2005–2013. MMWR Morb Mortal Wkly Rep. 2014;63(47):1108–1112. - PMC - PubMed
    1. Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes. J Public Health Pol. 2011;32(1):16–31. doi: 10.1057/jphp.2010.41. - DOI - PubMed
    1. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska-Czapla M, Rosik-Dulewska C, Havel C. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23:133–139. doi: 10.1136/tobaccocontrol-2012-050859. - DOI - PMC - PubMed
    1. Hajek P, Etter J-F, Benowitz N, Eissenberg T, McRobbie H. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction. 2014;109(11):1801–10. doi: 10.1111/add.12659. - DOI - PMC - PubMed

Publication types

Associated data